Announcements Trials
Browse Landscape

Phase

Phase NA 2

Status

Unknown 2Completed 2

Sponsor Class

UNKNOWN 1OTHER 1

Study Type

Interventional 2

Sponsor

Cancer Type

Endocrine 1

Conditions

Prolactinoma 2Recurrence 1Pituitary Neoplasms 1

Interventions

Exercise 57Radiotherapy 49Blood Specimen Collection 45Radiosurgery 35Drug Therapy 33Standard of Care 32Surgical Procedures, Operative 30Magnetic Resonance Spectroscopy 26Laparoscopy 24Cisplatin 24Cyclophosphamide 23Biopsy 23Acupuncture Therapy 23Magnetic Resonance Imaging 20Saline Solution 19Radiofrequency Ablation 19Endoscopic Mucosal Resection 19Control Groups 19camrelizumab 16Propofol 16Metformin 16Cytarabine 16Surveys and Questionnaires 15Preoperative Exercise 15Injections 15Fluorouracil 15anlotinib 14Radiotherapy, Intensity-Modulated 14Neoadjuvant Therapy 14Early Intervention, Educational 14

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Phase NA × Unknown × Cabergoline × Clear all
NCT03457389 2020-03-18

Comparison of Treatment Outcome of Cabergoline According to Target Prolactin Levels in Patients With Prolactinoma

Seoul National University Hospital

Phase NA Unknown
68 enrolled
Endocrine

Pituitary Neoplasms, Recurrence, Prolactinoma

NCT01143584 2010-06-14

Efficacy of Rapid Escalation of Cabergoline in Comparison to Conventional Dosing in Prolactin Secreting Macroadenomas.

PIMERIndia

Phase NA Unknown
20 enrolled

Prolactinoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡